Gene · 10578
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia restricts the generation of BCG-responsive polycytotoxic T cells. | Vaccine | 2026 | 41819641 | PubTator, text mining | PubMed |
| Risk Factors and Biomarkers for Immune Checkpoint Inhibitor-mediated Hepatotoxicity: Emerging Insights and Future Perspectives. | J Clin Transl Hepatol | 2026 | 41810106 | PubTator, text mining | PubMed |
| Phenotypically similar but functionally distinct NK cell populations within the human maternal-fetal interface. | Immunohorizons | 2026 | 41808348 | PubTator, text mining | PubMed |
| Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates. | PLoS One | 2026 | 41805702 | PubTator, text mining | PubMed |
| Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis. | Signal Transduct Target Ther | 2026 | 41803093 | PubTator, text mining | PubMed |
| Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2026 | 41803090 | PubTator, text mining | PubMed |
| Impact of Age and Gender on Serum Cytokine and Chemokine Levels: Analysis of 157 Healthy Subjects across Consecutive Age Groups. | Int Arch Allergy Immunol | 2026 | 41802125 | PubTator, text mining | PubMed |
| Dual Targeting of FAP-Directed Nanoparticles and FRα-Specific CAR-T Cells Induces Additive Anti-Tumor Effects in Triple-Negative Breast Cancer. | Int J Biol Sci | 2026 | 41800236 | PubTator, text mining | PubMed |
| Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor-reactive CX3CR1⁺GPR56⁺ T cells in hepatocellular carcinoma. | Theranostics | 2026 | 41799205 | PubTator, text mining | PubMed |
| Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer. | Theranostics | 2026 | 41799193 | PubTator, text mining | PubMed |
| The Immune Cell Atlas of "Longevity Molecular Tag": Identification of Principal Immune Cell Subsets and Their Underlying Molecular Regulatory Mechanisms. | Aging Cell | 2026 | 41784043 | PubTator, text mining | PubMed |
| Histological, ultrastructural, and single-cell profiling reveal immune-mediated remodeling in gallbladder inflammation. | Cell Tissue Res | 2026 | 41781757 | PubTator, text mining | PubMed |
| HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV. | Nat Commun | 2026 | 41776157 | PubTator, text mining | PubMed |
| Enumeration, Phenotyping, and Clinical Associations of Tissue-Resident T Cells in the Ecto- and Endocervix of Women Attending a Colposcopy Clinic. | Am J Reprod Immunol | 2026 | 41758064 | PubTator, text mining | PubMed |
| Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion. | medRxiv | 2026 | 41757162 | PubTator, text mining | PubMed |
| Systematic Comparison of Droplet-Based and Microwell-Based Platforms for Comprehensive Single-Cell Transcriptomic Analysis in Clinical Samples. | IET Nanobiotechnol | 2026 | 41755812 | PubTator, text mining | PubMed |
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
| The Fibro-Immune Landscape Across Organs: A Single-Cell Comparative Study of Human Fibrotic Diseases. | Int J Mol Sci | 2026 | 41752153 | PubTator, text mining | PubMed |
| Natural Killer Cell Phenotype and Function as a Predictive Factor for Treatment Response to Neoadjuvant Therapy in Breast Cancer Patients. | Int J Mol Sci | 2026 | 41751774 | PubTator, text mining | PubMed |
| A Simplified Strategy for Nanobody Production and Use Based on Functional GST-Nanobody Fusion Proteins. | Biomolecules | 2026 | 41750374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10578/papers?page=4